SINOVAC BIOTECH LTD Cost of Revenue
SINOVAC BIOTECH LTD (SVA) reported Cost of Revenue of $124.03 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-06-05.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-06-05
| Period end | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|
| 2025-12-31 | $124.03M 20-F · filed 2026-06-05 | |
| 2024-12-31 | $140.69M 20-F · filed 2026-06-05 | |
| 2023-12-31 | $146.85M 20-F · filed 2026-06-05 | $181.52M 20-F · filed 2024-04-29 |
| 2022-12-31 | $658.19M 20-F · filed 2026-04-30 | $684.46M 20-F · filed 2023-05-01 |
| 2021-12-31 | $988.92M 20-F · filed 2026-04-30 | $1.07B 20-F · filed 2022-04-29 |
| 2020-12-31 | $67.18M 20-F · filed 2023-05-01 | |
| 2019-12-31 | $32.47M 20-F · filed 2022-04-29 | |
| 2018-12-31 | $24.72M 20-F · filed 2021-04-22 | |
| 2017-12-31 | $20.24M 20-F · filed 2020-04-30 | |
| 2016-12-31 | $22.39M 20-F · filed 2019-04-29 | |
| 2015-12-31 | $18.41M 20-F · filed 2018-05-11 | $18.43M 20-F · filed 2016-04-25 |
| 2014-12-31 | $15.48M 20-F · filed 2017-11-22 | $16.49M 20-F · filed 2015-04-29 |
| 2013-12-31 | $20.50M 20-F · filed 2016-04-25 | $21.27M 20-F · filed 2014-04-16 |
| 2012-12-31 | $19.10M 20-F · filed 2015-04-29 | $19.10M 20-F/A · filed 2013-05-23 |
| 2011-12-31 | $21.13M 20-F · filed 2014-04-16 | $21.13M 20-F · filed 2012-04-12 |
| 2010-12-31 | $16.72M 20-F/A · filed 2013-05-23 | |
| 2009-12-31 | $20.06M 20-F · filed 2012-04-12 |